Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Primary progressive multiple sclerosis

Recruiting

Investigational

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational

Portugal

Participants:18–64 years

Contact Research Centre

Type 2 diabetes mellitus+2

Recruiting

Registered drug

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Psoriatic arthropathy

Recruiting

Investigational

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Focal segmental glomerulosclerosis

Recruiting

Investigational

A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

Investigational

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Registered drugNo placebo

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Registered drugNo placebo

Portugal

Participants:18–64 years
Substances:Bevacizumab

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Registered drug

A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Empasiprubart

Contact Research Centre

Sjogren's syndrome

Recruiting

InvestigationalNo placebo

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Dazodalibep

Contact Research Centre

Find therapies in clinical trials near you

821 trials match your criteria

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Colitis ulcerative

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

Renal disorder

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Primary progressive multiple sclerosis

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Type 2 diabetes mellitus+2

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Psoriatic arthropathy

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Focal segmental glomerulosclerosis

A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

Chronic spontaneous urticaria

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Colorectal cancer metastatic

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Chronic inflammatory demyelinating polyradiculoneuropathy

A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Sjogren's syndrome

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.